ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2026

Jan 12, 2026

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK: 0000949858
Period of Report: 2026-01-01

Reporting Person: Rubinstein Mark Lawrence (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	39600	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$4.52	2034-12-06	Common Stock (47000)		Direct
Stock Option (right to buy)	$3.10	2035-10-01	Common Stock (50000)		Direct

Footnotes

F1: 25% of the options became exercisable on September 30, 2025 and the remainder vest in thirty-six equal monthly installments thereafter.

F2: 25% of the options become exercisable on October 7, 2026 and the remainder vest in thirty-six equal monthly installments thereafter.